Gemfibrozil and its oxidative metabolites: quantification of aglycones, acyl glucuronides, and covalent adducts in samples from preclinical and clinical kinetic studies
Authors:
- Ann-Katrin GräfeAGAnn-Katrin Gräfe
- Gül BaktirGBGül Baktir
- Ernst MutschlerEMErnst Mutschler
- Hildegard Spahn-LangguthHSHildegard Spahn-Langguth
- 1 May 2000
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 741 (2) , 129-144
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Predictability of the covalent binding of acidic drugs in manLife Sciences, 1993
- In vitro and in vivo irreversible plasma protein binding of beclobric acid enantiomersChirality, 1993
- Acyl Glucuronides Revisited: Is the Glucuronidation Proces a Toxification as Well as a Detoxification Mechanism?Drug Metabolism Reviews, 1992
- In vivo covalent binding of clofibric acid to human plasma proteins and rat liver proteinsBiochemical Pharmacology, 1991
- Simultaneous determination of gemfibrozil and its metabolites in plasma and urine by a fully automated high performance liquid chromatographic systemBiomedical Chromatography, 1991
- Gemfibrozil absorption and elimination in kidney and liver diseaseJournal of Molecular Medicine, 1990
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Irreversible binding of zomepirac to plasma protein in vitro and in vivo.Journal of Clinical Investigation, 1986
- Liquid chromatographic determination of gemfibrozil and its metabolite in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Gas chromatographic determination of gemfibrozil and its metabolites in plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1984